|Hungry for more Regs & Eggs?
Click here for previous editions.
If you’re a true “Reg Head,” like me, you were eagerly awaiting the U.S. Department on Health and Human Services (HHS) to release the Substance Abuse and Mental Health Services Administration (SAMHSA) proposed reg to modify 42 CFR Part 2. For those who are just diving into health care regs, 42 CFR Part 2 governs the confidentiality of patient records for the treatment of substance use disorder (SUD). On August 22nd, SAMHSA finally issued the proposed reg.
One of the major policy debates around 42 CFR Part 2 has been whether this set of regulations should be modified to align more closely with HIPAA. Currently, under 42 CFR Part 2 requirements, the sharing of medical records for patients seeking treatment for SUD requires patient consent except under limited circumstances, including bona fide medical emergencies. Conversely, under HIPAA, health care providers and other “covered entities” can use protected health information about a patient for treatment, payment, or health care operations without the patient’s consent. There are differing opinions on whether the 42 CFR Part 2 patient consent requirements should more closely match with the HIPAA requirements, and therefore many stakeholders were anxiously waiting to see if SAMHSA would propose such an alignment in the reg. However, the long-awaited reg DOES NOT do so. In fact, when releasing the reg, HHS leadership stated that they do not believe that the Department actually has the legal authority to completely align 42 CFR Part 2 and HIPAA and that congressional action is necessary.
Instead, SAMHSA proposes smaller modifications to 42 CFR Part 2 aimed at advancing care coordination for patients with SUD and clarifying existing policies for 42 CFR Part 2 treatment Programs (federally assisted alcohol or drug abuse programs) and other health care providers. Some of the major proposals include:
ACEP recognizes that the current 42 CFR Part 2 requirements may be confusing to those who provide treatment to patients with SUD. We are still reviewing this proposed reg to see if it provides the needed clarity to help you better serve your patients. In the meantime, we would love to hear your thoughts on the reg! If you have any comments or feedback, please send them to me at email@example.com. Comments on the reg are due on October 25.
Until next week, this is Jeffrey saying, enjoy reading regs with your eggs!
If you have any questions or want to weigh in on other regulatory items, feel free to email me: firstname.lastname@example.org.
Jeffrey Davis is the Director of Regulatory Affairs at the American College of Emergency Physicians (ACEP). He manages ACEP’s formal response to federal policies and works with federal agencies and other stakeholders to help advance ACEP’s federal affairs agenda. Prior to that, Jeffrey worked in the Budget Office at the U.S. Department of Health and Human Services for nearly eight years. Jeffrey came to the Government as a Presidential Management Fellow, and in his position in the Budget Office, he advised top level officials on major budgetary and policy considerations within Medicare and prepared detailed analyses of Medicare regulations and legislation. Jeffrey has a Masters of Science in Health Policy and Management from the Harvard T.H. Chan School of Public Health and a Bachelors of Arts degree from Duke University.